Amid a swirl of controversy over leadership, budget priorities, and stifling bureaucracy, the new organizational structure of the National Cancer Institute (NCI) went into effect October 1. The reorganization was prompted by internal, agency, and congressional studies.
Under the restructuring, many programs, laboratories, and branches fall under new or redesigned divisions, with an eye toward streamlining the agency, revamping its intramural program, and opening lines of communication.
FOCUS ON ATTENTION: The performance of the new NCI director Richard D. Kalusner is seen as the key to a successful institute reorganization.
The latest changes in NCI's structure are being put into effect by the institute's new director, Richard Klausner, whose performance is considered by many as the key to the effort. Klausner assumed the NCI directorship August 1. Formerly the director of the Cell Biology and Metabolism Branch of the National Institute of Child Health...